Verzenio 150 mg

VERZENIO 150 MG tablets contain abemaciclib, a medication used in cancer treatment. This oral tablet is manufactured by Eli Lilly Canada Inc. and is designed to support specific therapeutic needs.

VERZENIO 150 MG tablets are generally used in the treatment of certain types of cancer. Abemaciclib is a type of CDK4/6 inhibitor, which may help slow the growth of cancer cells. This medication is typically prescribed as part of a broader treatment plan, often in combination with other therapies.

Common effects of VERZENIO 150 MG tablets may include fatigue, nausea, and diarrhea. Some individuals might also experience a decrease in white blood cell counts. It's important to discuss any persistent or severe effects with a healthcare provider.

VERZENIO 150 MG tablets should be handled with care. Store the medication in a cool, dry place away from direct sunlight. Always follow the instructions provided by your healthcare provider regarding the use of this medication.

VERZENIO 150 MG tablets may interact with certain medications, including those that affect liver enzymes. It's important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.